Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)

Ilyang Pharmaceutical Co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	197,427	281,258	349,981	510,655	1,197,901	410,527
Market Cap Growth	-6.82%	-19.64%	-31.46%	-57.37%	191.80%	-17.82%
Enterprise Value	332,964	394,941	436,337	605,360	1,322,774	552,846
Last Close Price	10960.00	15650.00	19161.53	27568.46	64205.98	21960.22
PE Ratio	-	-	18.63	35.50	110.11	41.11
Forward PE	-	49.90	49.90	49.90	49.90	49.90
PS Ratio	0.54	0.76	0.91	1.38	3.49	1.26
PB Ratio	0.85	1.07	1.20	1.88	4.89	1.84
P/TBV Ratio	1.04	1.27	1.53	2.33	5.92	2.14
P/FCF Ratio	-	21.16	13.54	9.44	25.32	12.07
P/OCF Ratio	103.25	14.51	11.69	7.62	20.84	11.34
EV/Sales Ratio	0.91	1.07	1.14	1.63	3.85	1.70
EV/EBITDA Ratio	18.35	10.28	8.16	11.28	28.29	12.98
EV/EBIT Ratio	55.52	15.92	10.80	14.76	38.79	17.00
EV/FCF Ratio	-13.82	29.71	16.88	11.19	27.96	16.25
Debt / Equity Ratio	0.45	0.32	0.29	0.38	0.42	0.58
Debt / EBITDA Ratio	3.74	2.22	1.60	1.90	2.20	3.02
Debt / FCF Ratio	-	6.40	3.32	1.89	2.18	3.78
Asset Turnover	0.71	0.77	0.77	0.80	0.78	0.75
Inventory Turnover	2.21	2.77	3.28	3.72	3.17	2.83
Quick Ratio	0.51	0.51	0.71	0.76	0.60	0.58
Current Ratio	0.89	0.92	1.07	1.03	0.92	0.95
Return on Equity (ROE)	0.80%	0.04%	11.26%	10.05%	9.21%	9.06%
Return on Assets (ROA)	2.51%	3.24%	5.09%	5.49%	4.86%	4.67%
Return on Capital (ROIC)	3.39%	4.27%	6.72%	7.10%	6.10%	5.76%
Earnings Yield	-0.40%	-0.91%	5.50%	2.82%	0.91%	2.43%
FCF Yield	-12.21%	4.73%	7.39%	10.60%	3.95%	8.29%
Dividend Yield	1.37%	0.96%	-	-	-	-
Payout Ratio	0.00%	-	20.49%	61.00%	45.05%	58.24%
Buyback Yield / Dilution	0.42%	0.59%	0.44%	-	-	0.29%
Total Shareholder Return	1.79%	1.55%	0.44%	-	-	0.29%

Source: S&P Capital IQ. Standard template. Financial Sources.